Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
23andMe is an at-home DNA genetic testing service for individual consumers. Rather than a traditional enterprise SaaS product, it is a digital health product built around a “testing kit + online reports + membership subscription” model. Users collect a saliva sample and mail it in; after the lab completes genotyping, results are delivered to a secure online account.
Its basic Ancestry Service focuses on ancestry analysis, covering 4,500+ regions and offering features such as ancestry composition, ancestry timeline, DNA Relative Finder, family tree, haplogroups, and Neanderthal DNA. 23andMe+ Premium adds health-related capabilities on top of this, including 50+ genetic health screenings, 100+ health reports, polygenic risk scores (PRS), pharmacogenomics, and health action tools, with new reports added over time as science advances. Total Health is positioned as a higher-tier health and longevity management offering, including next-generation DNA analysis, exome sequencing, and blood testing, but it requires completion of a questionnaire and review by a third-party clinician.
The page lists Ancestry Service at $99; 23andMe+ Premium at $199, renewing at $69/year; and 23andMe+ Total Health at $499, renewing at $199/year. Premium and Total Health are marked as FSA/HSA Eligible. Overall, the model combines a one-time hardware/testing purchase with an annual subscription, making it suitable for users who want to receive new health insights over the long term.
Its strengths include highly granular ancestry breakdowns, a broad range of report categories, and an emphasis on FDA clearance for certain health reports, privacy-focused design, and secure online accounts. The limitations are also clear: health risk and pharmacogenomics reports cannot be used for diagnosis or for changing treatment independently, and important results still require clinical confirmation; pharmacogenomic coverage is limited; and the page provides no information on team collaboration, permission management, APIs, or enterprise integrations, so it is not suitable to evaluate as an enterprise software platform.
It is best suited to adults interested in personal ancestry, genetic relationships, inherited health risks, and discussions around drug metabolism. Users in China should pay extra attention to cross-border access, sample shipping, payment, and compliance requirements for medical data and genetic information. The page does not provide information on mainland China access, payments, or localization, so china_access is judged to be unknown. Comparable options include AncestryDNA, MyHeritage DNA, and FamilyTreeDNA, or users may choose a locally compliant genetic testing provider.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on 23andme.asia official site.
23andme.asia is an United States Health provider. TG4G tracks its product information, with monthly pricing from $99.00, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach 23andme.asia directly.